Pharma Stocks
- All
- News
- Videos
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
Mankind Pharma IPO: 5 Things To Know
The long-awaited Mankind Pharma IPO is opening soon. Find out key details inside.
-
Mankind Pharma Share Sale: IPO (Public Offer) To Open On April 25
The initial share sale of drug maker Mankind Pharma will open for public subscription on April 25.
-
Specialty Chemical Company Slips 5% On Market Debut. Here Are The Details...
This company recently concluded its IPO on the BSE SME segment where the issue price was set at Rs 73.
-
ChatGPT Was Asked To Choose Between Laurus And Divis Labs. Here's What It Replied.
How ChatGPT refused to compare two pharma stocks and left the decision to us.
-
Nifty, Sensex Close On Flat Note
Among Sensex stocks, Hindustan Unilever rose the most by 1.89 per cent. Sun Pharma, Tata Motors, Infosys, TCS, Tech Mahindra, HCL Tech, SBI, Kotak Bank, HDFC twins, and Nestle were among major gainers.
-
Pharma Stock Rally May Not Last In 2023 Despite Rise In Covid Cases
With Covid cases rising, pharma stocks have once again started to rally. But my technical indicators suggest the rally may not last.
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Here's Why Cipla Share Price Is Rising
Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.
-
Sensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th Day
Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners.
-
Aurobindo Pharma Stock Falls Nearly 7% In Early Trade, Hits 52-Week Low After Q2 Results
Shares of Aurobindo Pharma on Monday fell nearly 7 per cent in early trade after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30, 2022.
-
Why Is Sanofi India's Share Price Falling?
The pharma market is expected to grow due to various factors including improved healthcare, awareness and government interventions and Sanofi India will be a big beneficiary.
-
Udaan Starts Multiple Deliveries Per Day For Pharmacies In Six Cities
Lightspeed Venture Partners-backed B2B e-commerce firm Udaan has started delivering stocks to pharmacies four times a day across six cities and plans to scale up the service to other places after six to eight months, the company said on Thursday.
-
One Long-Term Investing Theme To Find Multibagger Stocks
Indian economy is in a nascent stage of a capex revival. The last time this happened, the stock markets saw a multi-year bull run.
-
The Only Theme I'm Willing To Bet On For Multibagger Gains ...
Indian economy is in a nascent stage of a capex revival. The last time this happened, the stock markets saw a multi-year bull run.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
Mankind Pharma IPO: 5 Things To Know
The long-awaited Mankind Pharma IPO is opening soon. Find out key details inside.
-
Mankind Pharma Share Sale: IPO (Public Offer) To Open On April 25
The initial share sale of drug maker Mankind Pharma will open for public subscription on April 25.
-
Specialty Chemical Company Slips 5% On Market Debut. Here Are The Details...
This company recently concluded its IPO on the BSE SME segment where the issue price was set at Rs 73.
-
ChatGPT Was Asked To Choose Between Laurus And Divis Labs. Here's What It Replied.
How ChatGPT refused to compare two pharma stocks and left the decision to us.
-
Nifty, Sensex Close On Flat Note
Among Sensex stocks, Hindustan Unilever rose the most by 1.89 per cent. Sun Pharma, Tata Motors, Infosys, TCS, Tech Mahindra, HCL Tech, SBI, Kotak Bank, HDFC twins, and Nestle were among major gainers.
-
Pharma Stock Rally May Not Last In 2023 Despite Rise In Covid Cases
With Covid cases rising, pharma stocks have once again started to rally. But my technical indicators suggest the rally may not last.
-
Why Are Pharma Stocks Rising?
The recent decline in the stock market has unnerved investors and traders alike. But pharma stocks are rising. Find out why and other implications.
-
Here's Why Cipla Share Price Is Rising
Pharma stocks are in focus amid renewed fears of Covid outbreaks and have rallied between 5-15% in the past couple of days.
-
Sensex, Nifty End At New All-Time Highs, Sustain Momentum For 6th Day
Among the Sensex pack, Hindustan Unilever, Sun Pharma, Nestle, Dr Reddy's, Tata Steel, ICICI Bank, Titan and HCL Technologies were the major winners.
-
Aurobindo Pharma Stock Falls Nearly 7% In Early Trade, Hits 52-Week Low After Q2 Results
Shares of Aurobindo Pharma on Monday fell nearly 7 per cent in early trade after the company reported a 41 per cent decline in its consolidated net profit for the second quarter ended September 30, 2022.
-
Why Is Sanofi India's Share Price Falling?
The pharma market is expected to grow due to various factors including improved healthcare, awareness and government interventions and Sanofi India will be a big beneficiary.
-
Udaan Starts Multiple Deliveries Per Day For Pharmacies In Six Cities
Lightspeed Venture Partners-backed B2B e-commerce firm Udaan has started delivering stocks to pharmacies four times a day across six cities and plans to scale up the service to other places after six to eight months, the company said on Thursday.
-
One Long-Term Investing Theme To Find Multibagger Stocks
Indian economy is in a nascent stage of a capex revival. The last time this happened, the stock markets saw a multi-year bull run.
-
The Only Theme I'm Willing To Bet On For Multibagger Gains ...
Indian economy is in a nascent stage of a capex revival. The last time this happened, the stock markets saw a multi-year bull run.
